Incidence of Adverse Events for PD-1/PD-L1 Inhibitors Underscores Toxicity Risk

A review and meta-analysis in JAMA Oncology evaluated the incidence of treatment-related adverse events in patients receiving PD-1 or PD-L1 therapy.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news